Title: Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
Journal: Journal of medicinal chemistry 20140626
Title: Mahajan S, et al. VX-509 is a potent and selective Janus kinase 3 (JAK3) inhibitor that attenuates inflammation in animal models of autoimmune disease. J Pharmacol Exp Ther. 2015 Mar 11. pii: jpet.114.221176.